🇺🇸 FDA
Pipeline program

Insulin Glargine

11806

Approved small_molecule completed

Quick answer

Insulin Glargine for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at Eli Lilly and Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly and Company
Indication
Diabetes Mellitus, Type 2
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials